Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

D Champa, MA Russo, XH Liao, S Refetoff… - Endocr Relat …, 2014 - erc.bioscientifica.com
Poorly differentiated tumors of the thyroid gland (PDTC) are generally characterized by a
poor prognosis due to their resistance to available therapeutic approaches. The relative …
被引用次数：35 相关文章
[HTML] nih.gov

[HTML][HTML] Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

D Champa, MA Russo, XH Liao, S Refetoff… - Endocrine-related …, 2014 - ncbi.nlm.nih.gov
Poorly differentiated tumors of the thyroid gland (PDTC) are generally characterized by a
poor prognosis due to their resistance to available therapeutic approaches. The relative …

[引用][C] Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

D Champa, MA Russo, XH Liao, S Refetoff… - Endocrine Related …, 2014 - cir.nii.ac.jp
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering
Bcl2a1 and Mcl1 overexpression | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

D Champa, MA Russo, XH Liao… - Endocrine-related …, 2014 - pubmed.ncbi.nlm.nih.gov
Poorly differentiated tumors of the thyroid gland (PDTC) are generally characterized by a
poor prognosis due to their resistance to available therapeutic approaches. The relative …

Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

D Champa, MA Russo, XH Liao… - Endocrine …, 2014 - einstein.elsevierpure.com
Poorly differentiated tumors of the thyroid gland (PDTC) are generally characterized by a
poor prognosis due to their resistance to available therapeutic approaches. The relative …
[PDF] academia.edu

[PDF][PDF] Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression

D Champa, MA Russo, XH Liao, S Refetoff… - Endocrine-Related …, 2014 - academia.edu
Poorly differentiated tumors of the thyroid gland (PDTC) are generally characterized by a
poor prognosis due to their resistance to available therapeutic approaches. The relative …

Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression.

D Champa, MA Russo, XH Liao, S Refetoff… - Endocrine-related …, 2014 - europepmc.org
Poorly differentiated tumors of the thyroid gland (PDTC) are generally characterized by a
poor prognosis due to their resistance to available therapeutic approaches. The relative …